LEP and metabolic dysfunction-associated steatotic liver disease: Patients with SS have increased body fat, insulin resistance (IR), dyslipidemia, coagulation abnormalities, increased leptin, low-grade inflammation, endothelial dysfunction (ED), and non-alcoholic fatty liver disease (NAFLD) (6, 10–14).